BOLD U 250

DESCRIPTION
Boldenone Undecylenate 250 is an oily solution of boldenone undecylenate for IM injection. Boldenone Undecylenate 250 is designed to release boldenone slowly from the injection site. Boldenone serum levels will remain elevated for 5 to 8 days after administration. Boldenone is an anabolic steroid possessing anabolic properties with moderate androgenic activity. Anabolic and androgenic agents are widely used in the treatment of catabolic processes where accelerated strength and muscular development are indicated.

INDICATIONS
Boldenone Undecylenate 250 is indicated as an alternate or adjunctive therapy in patients for the promotion of weight gain following: weight loss and/or muscular atrophy associated with extensive surgery, chronic infections, long term hospitali- zation, or severe trauma. For increased RBC in severe anemic patients where first-line therapy is contraindicated. For promotion of increased appetite in patients with appetite limited intake. Boldenone should be considered only as an adjunctive therapy together with other androgenic medications.

ADVERSE REACTIONS
Male: Gynecomastia, excessive frequency and duration of penile erections, oligospermia.
Skin and Appendages: Hirsutism, male pattern baldness and acne, gynecomastia.
Fluid/electrolyte Disturbances: Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates.
Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests; rarely, hepatocellular neoplasms, peliosis hepatis, hepatic adenomas, and
cholestatic hepatitis.
Hematologic: Suppression of clotting factors II, V, VII, & X: bleeding in patients on anti- coagulant therapy.
Nervous System: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Other: Serum lipid changes, hypercalcaemia, hypertension, oedema, priapism, and potentiation of sleep apnea.

CONTRAINDICATIONS
Patients with known hypersensitivity to any ingredients in this product. IA Patients with known or suspected carcinomas of the breast, testis, or prostate. Patients with severe heart disease, liver disease, or kidney disease or with a history of epilepsy. Products containing androgens should not be used by women as they may cause and fetal harm. virilization

DOSAGE AND ADMINISTRATION
Dosage has not been established. Use only pursuant to instructions of a qualified physician.

PRESENTATION
Boldenone Undecylenate 250 mg/ml, 10 ml multiple dose vial.

STORAGE
Store in a cool dry place between 15 – 25°C, Protect from beau light.